New York State Common Retirement Fund’s Palvella Therapeutics PVLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.59M Sell
10,430
-10,712
-51% -$1.3M ﹤0.01% 1553
2026
Q1
$2.64M Buy
21,142
+3,827
+22% +$399K ﹤0.01% 1271
2025
Q4
$1.81M Buy
17,315
+14,515
+518% +$1.24M ﹤0.01% 1443
2025
Q3
$176K Sell
2,800
-2,100
-43% -$93.6K ﹤0.01% 2354
2025
Q2
$110K Buy
+4,900
New +$115K ﹤0.01% 2521
2021
Q3
Sell
-5
Closed -$2K 3546
2021
Q2
$2K Sell
5
-475
-99% -$104K ﹤0.01% 3340
2021
Q1
$99K Hold
480
﹤0.01% 3075
2020
Q4
$96K Hold
480
﹤0.01% 3038
2020
Q3
$79K Hold
480
﹤0.01% 3029
2020
Q2
$119K Hold
480
﹤0.01% 2867
2020
Q1
$88K Hold
480
﹤0.01% 2812
2019
Q4
$139K Hold
480
﹤0.01% 2898
2019
Q3
$131K Hold
480
﹤0.01% 2954
2019
Q2
$180K Hold
480
﹤0.01% 2878
2019
Q1
$129K Hold
480
﹤0.01% 2885
2018
Q4
$102K Hold
480
﹤0.01% 2960
2018
Q3
$215K Sell
480
-250
-34% -$109K ﹤0.01% 2799
2018
Q2
$296K Buy
730
+317
+77% +$151K ﹤0.01% 2686
2018
Q1
$225K Hold
413
﹤0.01% 2694
2017
Q4
$249K Hold
413
﹤0.01% 2654
2017
Q3
$190K Buy
413
+214
+108% +$91.4K ﹤0.01% 2804
2017
Q2
$80K Buy
+199
New +$58.2K ﹤0.01% 3116

Other funds holding PVLA

New York State Common Retirement Fund's PVLA Position: Q2 2026 in Review

New York State Common Retirement Fund reduced its Palvella Therapeutics (PVLA) stake by 51% in Q2 2026, selling an estimated $1.3M and leaving 10,430 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1553.

New York State Common Retirement Fund first reported a position in PVLA in Q2 2017 and has held it in 22 quarters since. The position peaked at $2.64M in Q1 2026. 63 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

  • New York State Common Retirement Fund held 10,430 shares of Palvella Therapeutics worth $1.59M as of Q2 2026.
  • New York State Common Retirement Fund sold 10,712 Palvella Therapeutics shares in Q2 2026, an estimated $1.3M.
  • Palvella Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1553 holding.
  • New York State Common Retirement Fund first reported a position in Palvella Therapeutics in Q2 2017 and has held it in 22 quarters since.
  • New York State Common Retirement Fund's Palvella Therapeutics position peaked at $2.64M in Q1 2026.
  • 63 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.